Policy Tracker · Patient Lens · July 24, 2026

Another Ozempic patient wants a judge to rule on how it's priced

Two separate lawsuits now argue Novo Nordisk owes patients answers about what they were charged and why.

2 developments affecting GLP-1 access were tracked on Thursday, July 23, 2026, across 1 category. Each entry links to the full record.

## Courts and enforcement

**[Patient sues Novo Nordisk over GLP-1 drug practices](/lawsuits/cl-73669214)**.

**[Tabor sues Novo Nordisk over Ozempic and Wegovy practices](/lawsuits/cl-73667158)**.

By Amanda Bonello

Originally published by Patient Lens on GLP-1 Laws, operated by GLP-1 Studio LLC — a for-profit company founded by the Collective's Executive Director. Republished here in full, with permission, at no cost. The Collective pays nothing for it and receives no payment for publishing it. How this works.